190 related articles for article (PubMed ID: 37963187)
1. Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis.
Ko JH; Lambert KE; Bhattacharya D; Lee MC; Colón CI; Hauser H; Sage J
Cancer Res; 2024 Jan; 84(2):226-240. PubMed ID: 37963187
[TBL] [Abstract][Full Text] [Related]
2. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
Semenova EA; Kwon MC; Monkhorst K; Song JY; Bhaskaran R; Krijgsman O; Kuilman T; Peters D; Buikhuisen WA; Smit EF; Pritchard C; Cozijnsen M; van der Vliet J; Zevenhoven J; Lambooij JP; Proost N; van Montfort E; Velds A; Huijbers IJ; Berns A
Cell Rep; 2016 Jul; 16(3):631-43. PubMed ID: 27373156
[TBL] [Abstract][Full Text] [Related]
4. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.
Denny SK; Yang D; Chuang CH; Brady JJ; Lim JS; Grüner BM; Chiou SH; Schep AN; Baral J; Hamard C; Antoine M; Wislez M; Kong CS; Connolly AJ; Park KS; Sage J; Greenleaf WJ; Winslow MM
Cell; 2016 Jul; 166(2):328-342. PubMed ID: 27374332
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor I/B is an oncogene in small cell lung cancer.
Dooley AL; Winslow MM; Chiang DY; Banerji S; Stransky N; Dayton TL; Snyder EL; Senna S; Whittaker CA; Bronson RT; Crowley D; Barretina J; Garraway L; Meyerson M; Jacks T
Genes Dev; 2011 Jul; 25(14):1470-5. PubMed ID: 21764851
[TBL] [Abstract][Full Text] [Related]
6. The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer.
Gao G; Hausmann S; Flores NM; Benitez AM; Shen J; Yang X; Person MD; Gayatri S; Cheng D; Lu Y; Liu B; Mazur PK; Bedford MT
Nat Commun; 2023 Jan; 14(1):363. PubMed ID: 36690626
[TBL] [Abstract][Full Text] [Related]
7. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of small cell lung cancer metastasis.
Ko J; Winslow MM; Sage J
EMBO Mol Med; 2021 Jan; 13(1):e13122. PubMed ID: 33296145
[TBL] [Abstract][Full Text] [Related]
9. Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin.
Yang D; Denny SK; Greenside PG; Chaikovsky AC; Brady JJ; Ouadah Y; Granja JM; Jahchan NS; Lim JS; Kwok S; Kong CS; Berghoff AS; Schmitt A; Reinhardt HC; Park KS; Preusser M; Kundaje A; Greenleaf WJ; Sage J; Winslow MM
Cancer Discov; 2018 Oct; 8(10):1316-1331. PubMed ID: 30228179
[TBL] [Abstract][Full Text] [Related]
10. Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.
Becker-Santos DD; Thu KL; English JC; Pikor LA; Martinez VD; Zhang M; Vucic EA; Luk MT; Carraro A; Korbelik J; Piga D; Lhomme NM; Tsay MJ; Yee J; MacAulay CE; Lam S; Lockwood WW; Robinson WP; Jurisica I; Lam WL
J Pathol; 2016 Oct; 240(2):161-72. PubMed ID: 27357447
[TBL] [Abstract][Full Text] [Related]
11. An overlapping set of genes is regulated by both NFIB and the glucocorticoid receptor during lung maturation.
Lajoie M; Hsu YC; Gronostajski RM; Bailey TL
BMC Genomics; 2014 Mar; 15():231. PubMed ID: 24661679
[TBL] [Abstract][Full Text] [Related]
12. miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.
Sun L; Fang Y; Wang X; Han Y; Du F; Li C; Hu H; Liu H; Liu Q; Wang J; Liang J; Chen P; Yang H; Nie Y; Wu K; Fan D; Coffey RJ; Lu Y; Zhao X; Wang X
Theranostics; 2019; 9(26):8409-8425. PubMed ID: 31754405
[No Abstract] [Full Text] [Related]
13. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
14. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.
Becker-Santos DD; Lonergan KM; Gronostajski RM; Lam WL
EBioMedicine; 2017 Aug; 22():2-9. PubMed ID: 28596133
[TBL] [Abstract][Full Text] [Related]
16. Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.
Grabowska MM; Kelly SM; Reese AL; Cates JM; Case TC; Zhang J; DeGraff DJ; Strand DW; Miller NL; Clark PE; Hayward SW; Gronostajski RM; Anderson PD; Matusik RJ
Endocrinology; 2016 Mar; 157(3):1094-109. PubMed ID: 26677878
[TBL] [Abstract][Full Text] [Related]
17.
Kumar VHS; Chaker El Khoury J; Gronostajski R; Wang H; Nielsen L; Ryan RM
Physiol Rep; 2017 Aug; 5(16):. PubMed ID: 28830981
[TBL] [Abstract][Full Text] [Related]
18. Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer.
Ciampricotti M; Karakousi T; Richards AL; Quintanal-Villalonga À; Karatza A; Caeser R; Costa EA; Allaj V; Manoj P; Spainhower KB; Kombak FE; Sanchez-Rivera FJ; Jaspers JE; Zavitsanou AM; Maddalo D; Ventura A; Rideout WM; Akama-Garren EH; Jacks T; Donoghue MTA; Sen T; Oliver TG; Poirier JT; Papagiannakopoulos T; Rudin CM
Cancer Discov; 2021 Dec; 11(12):3214-3229. PubMed ID: 34344693
[TBL] [Abstract][Full Text] [Related]
19. miR-365 promotes cutaneous squamous cell carcinoma (CSCC) through targeting nuclear factor I/B (NFIB).
Zhou M; Zhou L; Zheng L; Guo L; Wang Y; Liu H; Ou C; Ding Z
PLoS One; 2014; 9(6):e100620. PubMed ID: 24949940
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis.
Khan P; Siddiqui JA; Kshirsagar PG; Venkata RC; Maurya SK; Mirzapoiazova T; Perumal N; Chaudhary S; Kanchan RK; Fatima M; Khan MA; Rehman AU; Lakshmanan I; Mahapatra S; Talmon GA; Kulkarni P; Ganti AK; Jain M; Salgia R; Batra SK; Nasser MW
Mol Cancer; 2023 Jan; 22(1):1. PubMed ID: 36597126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
